BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27448301)

  • 21. Basic fibroblast growth factor causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory G1 events.
    Wang H; Rubin M; Fenig E; DeBlasio A; Mendelsohn J; Yahalom J; Wieder R
    Cancer Res; 1997 May; 57(9):1750-7. PubMed ID: 9135019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
    Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
    Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M
    Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
    Liu Y; Lu C; Shen Q; Munoz-Medellin D; Kim H; Brown PH
    Oncogene; 2004 Oct; 23(50):8238-46. PubMed ID: 15378019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
    Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y
    EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late-G1 cyclin-CDK activity is essential for control of cell morphogenesis in budding yeast.
    Moffat J; Andrews B
    Nat Cell Biol; 2004 Jan; 6(1):59-66. PubMed ID: 14688790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells.
    Wu G; Fan RS; Li W; Ko TC; Brattain MG
    Oncogene; 1997 Sep; 15(13):1555-63. PubMed ID: 9380407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apc10 and Ste9/Srw1, two regulators of the APC-cyclosome, as well as the CDK inhibitor Rum1 are required for G1 cell-cycle arrest in fission yeast.
    Kominami K; Seth-Smith H; Toda T
    EMBO J; 1998 Sep; 17(18):5388-99. PubMed ID: 9736616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocorticoids induce G1 as well as S-phase lengthening in normal human stimulated lymphocytes: differential effects on cell cycle regulatory proteins.
    Baghdassarian N; Catallo R; Mahly MA; Ffrench P; Chizat F; Bryon PA; Ffrench M
    Exp Cell Res; 1998 May; 240(2):263-73. PubMed ID: 9596999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
    Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
    Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-fetoprotein signal sequences: a proposed mechanism for subcellular localization and organelle targeting.
    Mizejewski GJ
    J Theor Biol; 1995 Sep; 176(1):103-13. PubMed ID: 7475095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational analysis of the Cy motif from p21 reveals sequence degeneracy and specificity for different cyclin-dependent kinases.
    Wohlschlegel JA; Dwyer BT; Takeda DY; Dutta A
    Mol Cell Biol; 2001 Aug; 21(15):4868-74. PubMed ID: 11438644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours.
    Coppée F; Depoortere F; Bartek J; Ledent C; Parmentier M; Dumont JE
    Oncogene; 1998 Aug; 17(5):631-41. PubMed ID: 9704929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S; Lowe M; Herliczek TW; Keyomarsi K
    Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonsecreted cytoplasmic alpha-fetoprotein: a newly discovered role in intracellular signaling and regulation. An update and commentary.
    Mizejewski GJ
    Tumour Biol; 2015 Dec; 36(12):9857-64. PubMed ID: 26162540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of the cell cycle inhibitor CIP1/WAF1 in lung alveolar epithelial cell growth arrest induced by glucocorticoids.
    Corroyer S; Nabeyrat E; Clement A
    Endocrinology; 1997 Sep; 138(9):3677-85. PubMed ID: 9275052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization.
    Petersen BO; Lukas J; Sørensen CS; Bartek J; Helin K
    EMBO J; 1999 Jan; 18(2):396-410. PubMed ID: 9889196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review and proposed action of alpha-fetoprotein growth inhibitory peptides as estrogen and cytoskeleton-associated factors.
    Mizejewski G; Smith G; Butterstein G
    Cell Biol Int; 2004; 28(12):913-33. PubMed ID: 15566961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.